Golden Green’s Vaxart VXRT Stock Holding History

Golden Green’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-34,210	Closed	-$195K	–	196
2020 Q4	$195K	Buy	+34,210	New	+$218K	0.18%	111

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Golden Green's VXRT Position: Q1 2021 in Review

Golden Green sold out of Vaxart (VXRT) in Q1 2021, closing a stake of 34,210 shares — an estimated $195K sold.

Golden Green first reported a position in VXRT in Q4 2020 and held it in 1 quarter. The position peaked at $195K in Q4 2020. 159 funds tracked by Wall St. Rank hold VXRT as of Q1 2021.

Golden Green reported no remaining Vaxart position as of Q1 2021 after selling out during the quarter.
Golden Green sold 34,210 Vaxart shares in Q1 2021, an estimated $195K.
Golden Green first reported a position in Vaxart in Q4 2020 and held it in 1 quarter.
Golden Green's Vaxart position peaked at $195K in Q4 2020.
159 funds tracked by Wall St. Rank held Vaxart as of Q1 2021.

Based on Golden Green's 13F filing for Q1 2021, filed 13 Apr 2021.